|
⚲
|
| Miragen Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001417827 |
| Sale | 2008-05-16 ($12.0 M Offered, $12.0 M Sold) |
| Fund | |
| Phone | 3035315952 |
| Address | 6200 Lookout Road Boulder, 80301 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Kyle Lefkoff | |
| Bruce Booth | |
| William Marshall | |
| Marvin Caruthers |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
BL-1011 Fund I, a series of AngelList Quant Fund Direct Inve
✚
|
0.0 | |
|
Blacher Joshua
✚
|
0.0 | |
|
Black-and-White Innovation Fund (Cayman) Ltd.
✚
|
0.0 | |
|
Black-and-White Innovation Fund LP
✚
|
0.0 | |
|
Black Angel Group Q4 24 II Nov 2024 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Black Angel Group Q4 24 I Oct 2024 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Black Bay Ventures X, LLC
✚
|
0.0 | |
|
Black Bear Value Fund, LP
✚
|
0.0 | |
|
Blackberg LP
✚
|
0.0 | |
|
BL-0923 Fund I, a series of Riverside Ventures, LP
✚
|
0.0 |